Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evolus Inc (EOLS)
NASDAQ:EOLS
Evolus (EOLS) Stock Price & Analysis
470 Followers
EOLS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.11 - $15.43
Previous Close$11.96
Volume325.09K
Average Volume (3M)545.65K
Market Cap
$748.82M
Enterprise Value$778.52M
Total Cash (Recent Filing)$96.96M
Total Debt (Recent Filing)$126.65M
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Jul 31, 2024EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.04
Shares Outstanding62,610,487
10 Day Avg. Volume593,509
30 Day Avg. Volume545,655
Standard Deviation0.25
R-Squared0.08
Alpha0.00956
Financial Highlights & Ratios
Price to Book (P/B)-13.38
Price to Sales (P/S)3.27
Price to Cash Flow (P/CF)-15.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.55
Enterprise Value/Gross Profit5.54
Enterprise Value/Ebitda-30.43
Forecast
1Y Price Target
$21.67Price Target Upside81.19% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Evolus News
PremiumCompany Announcements
Evolus Announces Board Appointments and Committee Changes
PremiumCompany Announcements
Evolus Shareholders Approve ESPP and Director Elections
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe new filler opportunity significantly expands the company’s Total Addressable Market (TAM).
Product PerformanceEvolus reported positive data for dermal filler products, with no treatment-related serious adverse events and a safety profile consistent across both products.
Sales GrowthJeuveau sales growth appears to be gaining momentum with increasing brand recognition and penetration of new accounts.
Bears Say
EarningsThe higher spending led to a wider non-GAAP EPS loss of -$0.21 compared to consensus estimates.
Market CompetitionKey risks include inability to capture market share due to competitive response.
Supply ChainKey risks include disruption to supply chain.
---
Ownership Overview
16.37% Insiders
9.68% Mutual Funds
16.26% Other Institutional Investors
57.70% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EOLS FAQ
What was Evolus Inc’s price range in the past 12 months?
Evolus Inc lowest stock price was $7.11 and its highest was $15.43 in the past 12 months.
What is Evolus Inc’s market cap?
Currently, no data Available
When is Evolus Inc’s upcoming earnings report date?
Evolus Inc’s upcoming earnings report date is Jul 31, 2024 which is in 10 days.
How were Evolus Inc’s earnings last quarter?
Evolus Inc released its earnings results on May 07, 2024. The company reported -$0.083 earnings per share for the quarter, beating the consensus estimate of -$0.152 by $0.069.
Is Evolus Inc overvalued?
According to Wall Street analysts Evolus Inc’s price is currently Undervalued.
Does Evolus Inc pay dividends?
Evolus Inc does not currently pay dividends.
What is Evolus Inc’s EPS estimate?
Evolus Inc’s EPS estimate is -$0.05.
How many shares outstanding does Evolus Inc have?
Evolus Inc has 62,610,490 shares outstanding.
What happened to Evolus Inc’s price movement after its last earnings report?
Evolus Inc reported an EPS of -$0.083 in its last earnings report, beating expectations of -$0.152. Following the earnings report the stock price went down -1.192%.
Which hedge fund is a major shareholder of Evolus Inc?
Among the largest hedge funds holding Evolus Inc’s share is Perceptive Advisors LLC. It holds Evolus Inc’s shares valued at 81M.
---
Evolus Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.67 (81.19% Upside)
$21.67 (81.19% Upside)
Blogger Sentiment
Bullish
EOLS Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 8.5%
Last 30 Days ▼ 8.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
57.57%
12-Months-Change
Fundamentals
Return on Equity
-472.61%
Trailing 12-Months
Asset Growth
41.15%
Trailing 12-Months
Company Description
Evolus Inc
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November, 2012 and is headquartered in Newport Beach, CA.
---
EOLS Company Deck
---
EOLS Earnings Call
Q1 2024
0:00 / 0:00
---
EOLS Stock 12 Month Forecast
Average Price Target
$21.67
▲(81.19% Upside)
Technical Analysis
Best Analysts Covering EOLS
1 Year
1 Year Success Rate
12/20 ratings generated profit
1 Year Average Return
+11.88%
reiterated a buy rating 2 months ago
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +11.88% per trade.
---